Drop-outs in tamoxifen prevention trials

Lancet. 1999 Mar 13;353(9156):930. doi: 10.1016/S0140-6736(05)75043-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticarcinogenic Agents / therapeutic use*
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / prevention & control*
  • Female
  • Humans
  • Incidence
  • Patient Dropouts / statistics & numerical data*
  • Tamoxifen / therapeutic use*

Substances

  • Anticarcinogenic Agents
  • Tamoxifen